0001415889-24-011120.txt : 20240418
0001415889-24-011120.hdr.sgml : 20240418
20240418160116
ACCESSION NUMBER: 0001415889-24-011120
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240416
FILED AS OF DATE: 20240418
DATE AS OF CHANGE: 20240418
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ware Olivia C
CENTRAL INDEX KEY: 0001663771
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41259
FILM NUMBER: 24854273
MAIL ADDRESS:
STREET 1: 11726 SAN VICENTE BLVD
STREET 2: SUITE 650
CITY: LOS ANGELES
STATE: CA
ZIP: 90049
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcellx, Inc.
CENTRAL INDEX KEY: 0001786205
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472855917
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 BRIDGE PARKWAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 240-327-0603
MAIL ADDRESS:
STREET 1: 800 BRIDGE PARKWAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
4
1
form4-04182024_080409.xml
X0508
4
2024-04-16
0001786205
Arcellx, Inc.
ACLX
0001663771
Ware Olivia C
C/O ARCELLX, INC.
800 BRIDGE PARKWAY
REDWOOD CITY
CA
94065
true
false
false
false
1
Common Stock
2024-04-16
4
M
0
9402
7.61
A
9402
D
Common Stock
2024-04-16
4
S
0
6790
55.3618
D
2612
D
Common Stock
2024-04-16
4
S
0
2612
56.0310
D
0
D
Stock Option (right to buy)
7.61
2024-04-16
4
M
0
9402
0
D
2032-05-16
Common Stock
9402
36806
D
The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on December 15, 2023.
Represents the weighted average share price of an aggregate total of 6,790 shares sold in the price range of $54.87 to $55.8699 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average share price of an aggregate total of 2,612 shares sold in the price range of $55.87 to $56.8699 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2022 Equity Incentive Plan) through each applicable vesting date, one-third (1/3rd) of the shares subject to the option will vest each year following Equity Grant Date on the same day of the month as the Equity Grant Date (or, if there is no corresponding day in a particular month, then the last day of the month) over three (3) years. "Equity Grant Date" shall mean May 16, 2022.
/s/ Michelle Gilson, as Attorney-in-Fact
2024-04-18